• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[中药延缓慢性肾脏病进展的机制]

[Mechanism of Chinese herbal medicine delaying progression of chronic kidney disease].

作者信息

Dou Chenhui, Wan Yigang, Sun Wei, Zhagn Huilang, Chen Jing, Shui Guangxing, Yao Jian

机构信息

Nanjing University of Traditional Chinese Medicine, Nanjing 210029, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2009 Apr;34(8):939-43.

PMID:19639770
Abstract

The pathomechanisms of the progression of chronic kidney disease (CKD) include glomerulosclerosis, renal interstitial fibrosis and renal arteriosclerosis. Chinese herbal medicine can delay the progression of CKD by ameliorating the harmful factors of these pathological changes, such as podocyte and slit diaphragm injury, nephrotoxicity of proteinuria, hyperactivity of renin-angiotensin-aldosterone system, cytokines over-expression, tubular epithelial myofibroblast transdifferentiation, hyperlipidemia and hypertension.

摘要

慢性肾脏病(CKD)进展的病理机制包括肾小球硬化、肾间质纤维化和肾动脉硬化。中药可以通过改善这些病理变化的有害因素来延缓CKD的进展,这些有害因素如足细胞和裂孔隔膜损伤、蛋白尿的肾毒性、肾素 - 血管紧张素 - 醛固酮系统的亢进、细胞因子过度表达、肾小管上皮细胞向肌成纤维细胞转分化、高脂血症和高血压。

相似文献

1
[Mechanism of Chinese herbal medicine delaying progression of chronic kidney disease].[中药延缓慢性肾脏病进展的机制]
Zhongguo Zhong Yao Za Zhi. 2009 Apr;34(8):939-43.
2
[Mechanisms and effects of chinese herbal medicine delaying progression of chronic renal failure].[中药延缓慢性肾衰竭进展的机制与作用]
Zhongguo Zhong Yao Za Zhi. 2011 May;36(9):1122-8.
3
[Progress in Japanese herbal medicine in treatment of chronic kidney disease].[日本汉方医学治疗慢性肾脏病的研究进展]
Zhongguo Zhong Yao Za Zhi. 2008 Jun;33(11):1348-52.
4
Progress of intervention of renal interstitial fibrosis with Chinese traditional herbal medicine.中药干预肾间质纤维化的研究进展
Di Yi Jun Yi Da Xue Xue Bao. 2002 Oct;22(10):946-8.
5
[Strategies and methods of integrated traditional Chinese and Western medicine in preventing and treating chronic kidney disease].中西医结合防治慢性肾脏病的策略与方法
Zhong Xi Yi Jie He Xue Bao. 2008 May;6(5):449-53. doi: 10.3736/jcim20080503.
6
The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study.N-乙酰半胱氨酸对非糖尿病慢性肾脏病患者蛋白尿及肾小管损伤标志物的影响。一项安慰剂对照、随机、开放、交叉研究。
Kidney Blood Press Res. 2008;31(6):404-10. doi: 10.1159/000185828. Epub 2008 Dec 18.
7
Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD.维生素D、蛋白尿、糖尿病肾病与慢性肾脏病的进展
Clin J Am Soc Nephrol. 2009 Sep;4(9):1523-8. doi: 10.2215/CJN.02010309. Epub 2009 May 28.
8
TGF-beta: a cytokine mediator of glomerulosclerosis and a target for therapeutic intervention.转化生长因子-β:肾小球硬化的细胞因子介质及治疗干预靶点。
Kidney Int Suppl. 1995 Jun;49:S59-61.
9
[Mechanism of Chinese herbal medicine delaying glomerulosclerosis in diabetic nephropathy].[中药延缓糖尿病肾病肾小球硬化的机制]
Zhongguo Zhong Yao Za Zhi. 2010 Feb;35(4):525-30. doi: 10.4268/cjcmm20100427.
10
The hazards of dual renin-angiotensin blockade in chronic kidney disease.
Arch Intern Med. 2009 Jun 8;169(11):1015-8. doi: 10.1001/archinternmed.2009.128.

引用本文的文献

1
Clinical Efficacy and Safety of Chinese Herbal Medicine in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials.中药治疗尿毒症瘙痒的临床疗效与安全性:随机对照试验的Meta分析
Pharmaceuticals (Basel). 2022 Oct 9;15(10):1239. doi: 10.3390/ph15101239.
2
Traditional Chinese Medicine in Treating Primary Podocytosis: From Fundamental Science to Clinical Research.中医治疗原发性足细胞病:从基础科学到临床研究
Front Pharmacol. 2022 Aug 8;13:932739. doi: 10.3389/fphar.2022.932739. eCollection 2022.
3
Traditional Chinese Medicine in the Treatment of Chronic Kidney Diseases: Theories, Applications, and Mechanisms.
中医治疗慢性肾脏病:理论、应用与机制
Front Pharmacol. 2022 Jul 18;13:917975. doi: 10.3389/fphar.2022.917975. eCollection 2022.
4
Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease.与血管紧张素II拮抗剂氯沙坦相比,补芪益肾方缓解肾衰竭(HERBAAL)试验的原理与设计:一项针对非糖尿病4期慢性肾病的随机对照试验
BMC Complement Altern Med. 2015 Sep 8;15:316. doi: 10.1186/s12906-015-0830-1.